David Goldemund

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Serum inflammatory biomarkers in Parkinson's disease

Michal Dufek, Markéta Hamanová, J Lokaj et al. · Parkinsonism & Related Disorders · 2008 · 98 citations

Life Sciences, Neurology, Neuroscience +12

Vascular pathology in patients with idiopathic Parkinson's disease

Ivan Rektor, David Goldemund, Kateřina Sheardová et al. · Parkinsonism & Related Disorders · 2008 · 65 citations

Medicine, Neurology, Pathology +14

Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial

Götz Thomalla, Jens Fiehler, Fabien Subtil et al. · The Lancet Neurology · 2024 · 65 citations · Full text

Medicine, Neurological Surgery, Surgery +17

Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis

Petr Aulický, Robert Mikulík, David Goldemund et al. · Journal of Neurology Neurosurgery & Psychiatry · 2009 · 48 citations

Medicine, Radiology, Cerebrovascular Neurosurgery +13